(Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2

From WikiMD's WELLNESSPEDIA


(Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is a synthetic peptide analog of the endogenous neuropeptide nociceptin, also known as orphanin FQ. This compound is of significant interest in the field of neuroscience and pharmacology due to its potential role in modulating pain and other physiological processes.

Structure and Synthesis[edit]

(Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is a modified peptide based on the nociceptin sequence. The modification involves a pseudopeptide bond between the first phenylalanine (Phe) and the second glycine (Gly) residue, where the typical peptide bond is replaced by a methyleneamino linkage (CH2-NH). This alteration is designed to enhance the stability of the peptide against enzymatic degradation, potentially increasing its bioavailability and duration of action.

Mechanism of Action[edit]

Nociceptin acts as a ligand for the nociceptin receptor (NOP receptor), which is a member of the opioid receptor family. However, unlike classical opioid receptors, the NOP receptor does not bind traditional opioids such as morphine. (Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is believed to act as an agonist at the NOP receptor, mimicking the effects of natural nociceptin.

Pharmacological Effects[edit]

Research suggests that (Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 may have analgesic properties, potentially offering pain relief without the addictive side effects associated with traditional opioids. Additionally, it may influence other physiological processes such as mood regulation, stress response, and appetite control.

Research and Clinical Implications[edit]

The study of (Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is ongoing, with researchers exploring its potential therapeutic applications in conditions such as chronic pain, anxiety disorders, and substance use disorders. Its unique mechanism of action makes it a promising candidate for developing new treatments that could circumvent the limitations of current opioid therapies.

Also see[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.